MoneyWorks4Me

Marksans Pharma informs about details of loss of certificate

14 Apr 2023 Evaluate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that it enclosed details of issue of duplicate share certificate against loss of share certificate on April 12, 2023 received from Registrar and Transfer Agent, Bigshare Services.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..